These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The role of p53 in death of IL-3-dependent cells in response to cytotoxic drugs. Palacios C; Gutierrez del Arroyo A; Silva A; Collins MK Oncogene; 2000 Jul; 19(31):3556-9. PubMed ID: 10918614 [TBL] [Abstract][Full Text] [Related]
23. Androgen suppressed apoptosis is modified in p53 deficient mice. Colombel M; Radvanyi F; Blanche M; Abbou C; Buttyan R; Donehower LA; Chopin D; Thiery JP Oncogene; 1995 Apr; 10(7):1269-74. PubMed ID: 7731676 [TBL] [Abstract][Full Text] [Related]
24. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage. Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822 [TBL] [Abstract][Full Text] [Related]
26. Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo. Yin L; Ghebranious N; Chakraborty S; Sheehan CE; Ilic Z; Sell S Hepatology; 1998 Jan; 27(1):73-80. PubMed ID: 9425920 [TBL] [Abstract][Full Text] [Related]
27. To die or not to die: how does p53 decide? Slee EA; O'Connor DJ; Lu X Oncogene; 2004 Apr; 23(16):2809-18. PubMed ID: 15077144 [TBL] [Abstract][Full Text] [Related]
28. The associated contributions of p53 and the DNA mismatch repair protein Msh6 to spontaneous tumorigenesis. Young LC; Keuling AM; Lai R; Nation PN; Tron VA; Andrew SE Carcinogenesis; 2007 Oct; 28(10):2131-8. PubMed ID: 17615258 [TBL] [Abstract][Full Text] [Related]
29. Modulations of glucocorticoid-induced apoptosis linked to the p53 deletion and to the apoptosis susceptibility gene Rapop1 (Radiation-induced apoptosis 1). Mori N; Yamate J; Stassen AP; Oka S; Okumoto M; Tsubura A; Akamatsu T; Sakuma S; Demant P Oncogene; 1999 Jul; 18(29):4282-5. PubMed ID: 10435642 [TBL] [Abstract][Full Text] [Related]
30. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. Luo JL; Yang Q; Tong WM; Hergenhahn M; Wang ZQ; Hollstein M Oncogene; 2001 Jan; 20(3):320-8. PubMed ID: 11313961 [TBL] [Abstract][Full Text] [Related]
31. Deficiency of Trp53 rescues the male fertility defects of Kit(W-v) mice but has no effect on the survival of melanocytes and mast cells. Jordan SA; Speed RM; Bernex F; Jackson IJ Dev Biol; 1999 Nov; 215(1):78-90. PubMed ID: 10525351 [TBL] [Abstract][Full Text] [Related]
32. The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosis. Sigal A; Matas D; Almog N; Goldfinger N; Rotter V Oncogene; 2001 Aug; 20(35):4891-8. PubMed ID: 11521201 [TBL] [Abstract][Full Text] [Related]
33. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer. Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332 [TBL] [Abstract][Full Text] [Related]
34. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742 [TBL] [Abstract][Full Text] [Related]
35. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia. Prasher JM; Elenitoba-Johnson KS; Kelley LL Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707 [TBL] [Abstract][Full Text] [Related]
36. Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout mice. van Kranen HJ; Westerman A; Berg RJ; Kram N; van Kreijl CF; Wester PW; de Gruijl FR Mutat Res; 2005 Apr; 571(1-2):81-90. PubMed ID: 15748640 [TBL] [Abstract][Full Text] [Related]
37. Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Hildesheim J; Bulavin DV; Anver MR; Alvord WG; Hollander MC; Vardanian L; Fornace AJ Cancer Res; 2002 Dec; 62(24):7305-15. PubMed ID: 12499274 [TBL] [Abstract][Full Text] [Related]
38. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line. Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698 [TBL] [Abstract][Full Text] [Related]
39. Response of Ewing tumor cells to forced and activated p53 expression. Kovar H; Pospisilova S; Jug G; Printz D; Gadner H Oncogene; 2003 May; 22(21):3193-204. PubMed ID: 12761489 [TBL] [Abstract][Full Text] [Related]
40. Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells. Li J; Zhang X; Sejas DP; Pang Q Leuk Res; 2005 Dec; 29(12):1415-23. PubMed ID: 15964625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]